INS50589
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INS50589, covering 2015-01-21 to 2016-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass [Phase 2]